Related Experiment Video

Updated: May 13, 2026

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Epidemiology of uveitis in children over a 10-year period

Lydia A L Clarke1, Yan Guex-Crosier, Michael Hofer

  • 1Department of Pediatrics, Lausanne University Hospital, Lausanne, Switzerland. lydiaclarke87@gmail.com

Clinical and Experimental Rheumatology
|February 26, 2013
PubMed

Insights

Paediatric uveitis, a serious eye condition in children, requires prompt diagnosis and management. This study highlights key demographics, causes, and outcomes, emphasizing collaborative care for better visual prognoses.

Area of Science:

  • Ophthalmology
  • Paediatric Rheumatology
  • Immunology

Background:

  • Paediatric uveitis presents unique challenges in diagnosis and management.
  • Understanding the specific epidemiological and clinical characteristics is crucial for effective treatment strategies.

Purpose of the Study:

  • To investigate the demographics, aetiologies, complications, treatments, and visual outcomes of paediatric uveitis in French-speaking Switzerland.
  • To provide insights into the management and prognosis of childhood uveitis.

Main Methods:

  • Retrospective chart review of paediatric uveitis patients (<16 years) from 2000-2009.
  • Inclusion of patients from two tertiary referral centres in Lausanne, Switzerland.

Main Results:

  • Seventy-nine children were analyzed, with idiopathic uveitis, JIA-related uveitis, and toxoplasmic retinochoroiditis being the most common diagnoses.
  • Visual acuity was ≥8/10 in 72% of eyes; common complications included cataract and glaucoma.
  • Systemic steroids and biological agents were utilized in 56% and 24% of inflammatory cases, respectively.

Conclusions:

  • Childhood uveitis can lead to severe visual impairment.
  • Accurate classification of causes and close collaboration between paediatric rheumatologists and ophthalmologists are vital for controlling inflammation and improving long-term visual outcomes.
Abstract

More Related Videos

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...